Skip to content
← Back to this collection

PUBLICATIONS · 1571539

Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
1992 May 1
First author
Robertson MJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Robertson MJ
      type
      Author
    2. name
      Soiffer RJ
      type
      Author
    3. name
      Freedman AS
      type
      Author
    4. name
      Rabinowe SL
      type
      Author
    5. name
      Anderson KC
      type
      Author
    6. name
      Ervin TJ
      type
      Author
    7. name
      Murray C
      type
      Author
    8. name
      Dear K
      type
      Author
    9. name
      Griffin JD
      type
      Author
    10. name
      Nadler LM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Robertson MJ
      type
      Author
    2. name
      Soiffer RJ
      type
      Author
    3. name
      Freedman AS
      type
      Author
    4. name
      Rabinowe SL
      type
      Author
    5. name
      Anderson KC
      type
      Author
    6. name
      Ervin TJ
      type
      Author
    7. name
      Murray C
      type
      Author
    8. name
      Dear K
      type
      Author
    9. name
      Griffin JD
      type
      Author
    10. name
      Nadler LM
      type
      Author
    bibliography ids
    1. nci-bib-0b78fd8abd5cbc7629f945f5
    book metadata
    content sha256
    a4aa520754e672d41daead4f1c2d3ae99f69c601fd3e9587a1cfda6c63c02e3c
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:1571539
      immutable id
      pubmed:1571539@a4aa520754e672d41daead4f1c2d3ae99f69c601fd3e9587a1cfda6c63c02e3c
      journal
      abbreviation
      Blood
      issn electronic
      Source null
      issn print
      0006-4971
      issue
      9
      name
      Blood
      nlm unique id
      7603509
      pages
      2229-36
      volume
      79
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        1571539
        provenance
        batch id
        4dd31a34efbe4b9fe1c1
        provider
        NCBI PubMed ESummary
        record sha256
        23919d71230e1a9c46045ef55f9ef1c7c555709c360dd541d061f8500b436920
        response sha256
        6a38fb0063e4902598a1efcc0d1821501cf82821747967b29fe13940a1d400ba
        retrieved at
        2026-09-09T23:45:07.034965+00:00
        publication date
        display
        1992 May 1
        precision
        day
        year
        1992
        publication types
        1. Clinical Trial
        2. Journal Article
        3. Research Support, Non-U.S. Gov't
        4. Research Support, U.S. Gov't, P.H.S.
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/1571539/
        title
        Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia.

        Preserved source evidence · Not medical advice